Humanfirst Therapeutics LLC is categorized under Medical Research in Silver Spring, MD and active since 2011.
Humanfirst Therapeutics LLC was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Mark Scheideler at the company’s single location by writing to 9600 Dewitt Drive # 1, Silver Spring, Maryland MD 20910 or by phoning (301) 346-8835. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Humanfirst Therapeutics LLC |
| Contact Person: | Mark Scheideler |
| Address: | 9600 Dewitt Drive # 1, Silver Spring, Maryland 20910 |
| Phone Number: | (301) 346-8835 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Humanfirst Therapeutics LLC was started in 2011 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Mark Scheideler for inquiries that concern Humanfirst Therapeutics LLC by calling the company number (301) 346-8835, as your correspondence is most welcome. Additionally, the physical location of the single location of Humanfirst Therapeutics LLC can be found at the coordinates 39.011995,-77.056445 as well as the street address 9600 Dewitt Drive # 1 in Silver Spring, Maryland 20910.
For its online presence, you may visit Humanfirst Therapeutics LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.